
Improving survival in pancreatic cancer with platinum-based chemotherapy
A small study of adults with the most common form of pancreatic cancer adds to…
A small study of adults with the most common form of pancreatic cancer adds to…
Scientists have identified a mutation that gives cancer cells resistance to the breakthrough cancer treatment…
The PARP inhibitor niraparib significantly improves the outcome of platinum-sensitive recurrent ovarian cancer, according to…